Biora Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

Biora Therapeutics

14/11/2022 22:41

* Biora Therapeutics Inc  BIOR.OQ  reported a quarterly
adjusted
loss of 3 cents​​ per share for the quarter ended in September.
The mean expectation of two analysts for the quarter was for a
loss of 7 cents per share.
    * Revenue fell 56% to $80.00 thousand from a year ago;
analysts
expected $50.00 thousand. 
    * Biora Therapeutics Inc's reported EPS for the quarter was
a loss
of 3 cents​.
    * The mean earnings estimate of analysts had risen by
about 28.6%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Biora Therapeutics Inc shares had fallen by 42.5% this
quarter and lost 86.7% so far this year.
    * The company reported a quarterly loss of $5.11 million.
    * Wall Street's median 12-month price target for Biora
Therapeutics Inc is $5.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
14 at 10:41 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.07          -0.03          Beat
 Jun. 30 2022      -0.12          -0.03          Beat
 Mar. 31 2022      -0.12          -0.08          Beat
 Dec. 31 2021      -0.16          -0.56          Missed